Treatment with masitinib led to lower blood levels of neurofilament light chain (NfL) and pro-inflammatory signaling ...

The signaling molecule IL-6, involved in inflammation, is associated with increasing frailty in relapsing-remitting MS, a ...

Three months of supplements with ellagic acid — an antioxidant — significantly eased fatigue, depression, and anxiety in MS ...

Non-pharmacological interventions, such as mindfulness and exercise, may improve sleep for MS patients, a meta-analysis of ...

While his multiple sclerosis is a big part of columnist Ben Hofmeistser's life, it's not his only health concern that deserves attention.

Upon receiving her master's degree, columnist Desiree Lama reflects on how her parents have supported her while she's living ...

The PoNS device has shown significant benefits in walking and balance in clinical trials, and benefits were seen in ...

The number of mitochondrial DNA copies may drop as MS progresses, suggesting a possible biomarker for disease progression, a ...

Quantum Biopharma plans to file an application by year's end seeking FDA clearance for a Phase 2 clinical trial testing Lucid ...

Higher levels of a type of bacteria called Lachnospiraceae in the gut may be a key risk factor for multiple sclerosis (MS), ...

Worsening disability may increase the risk of bone mineral density loss in MS, potentially leading to fractures, a study ...

Copaxone and generic versions of glatiramer acetate are injected under the skin at 20 mg/mL daily or 40 mg/mL three times a ...